News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

PressDigest

Valeant closes in on $9.7bn-plus takeover of Salix

Acquisitive Canadian pharmaceuticals company Valeant is on the verge of finalising an agreement to buy US gastrointestinal drug specialist Salix for more than $9.7bn, sources told the Financial Times.

WSJ Logo